Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of AST-120 and synbiotics on the gut microbiome and muscle health in chronic kidney disease
KCT0007834Phase 4Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of activated charcoal in chronic kidney disease (CKD), sponsored by HK inno.N Corporation. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
activated charcoal
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on KCT0007834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007834.